BioVenture
Munich, Bavariabioventure.de
Overview
BioVenture is a venture capital firm based in Munich, Germany, that provides seed, early, and later-stage funding to life science companies. It is associated with TVM Capital, with its managing partner also serving as the Chairman of the Board for BioVenture.
Portfolio Companies
5
Website
bioventure.deInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| PROVIREX Genome Editing Therapies GmbH | Aug 2026 | VC Round | Co-investor |
| PROVIREX Genome Editing Therapies GmbH | Oct 2022 | Series A | Lead |
| BiOligo Biotechnology (Shanghai) Co., Ltd. | Oct 2021 | Series A | Co-investor |
| PathologyWatch | Dec 2020 | Series A Extension | Lead |
| DiaMonTech AG | Sep 2019 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
See something wrong or outdated?